Moleculin Biotech, Inc.

$2.56
-0.02 (-0.78%)

Market Capitalization:

$13.66M

Moleculin Biotech Price Chart

Moleculin Biotech Price Chart2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM6:39 AM2.582.572.552.542.532.512.50

Moleculin Biotech Volume Chart

Moleculin Biotech Volume Chart2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM6:39 AM17.70K15.17K12.64K10.11K7.59K5.06K2.53K

Moleculin Biotech Market Segments

Premarket

+0.00(+0.00%)
Open$2.56
Close$2.56
Low$2.56
Low Change0.00 (0.00%)
High$2.56
High Change+0.00 (+0.00%)
Range$0.00
Volume400
Dollar Volume$1.02K

After Hours Yesterday

+0.02(+0.78%)
Open$2.54
Close$2.56
Low$2.50
Low Change-0.04 (-1.58%)
High$2.56
High Change+0.02 (+0.78%)
Range$0.06
Volume5.672K
Dollar Volume$14.52K

Regular Trading Hours Yesterday

+0.02(+0.78%)
Open$2.56
Close$2.58
Low$2.50
Low Change-0.06 (-2.34%)
High$2.62
High Change+0.06 (+2.50%)
Range$0.12
Volume124.487K
Dollar Volume$321.18K

Premarket Yesterday

+0.01(+0.27%)
Open$2.58
Close$2.59
Low$2.56
Low Change-0.02 (-0.78%)
High$2.59
High Change+0.01 (+0.27%)
Range$0.03
Volume700
Dollar Volume$1.81K

Moleculin Biotech Moving Averages

5 Day Moving Average (SMA5)$2.54
10 Day Moving Average (SMA10)$2.50
20 Day Moving Average (SMA20)$2.47
50 Day Moving Average (SMA50)$2.43
100 Day Moving Average (SMA100)$3.46
200 Day Moving Average (SMA200)$8.09

Moleculin Biotech Statistics

Average Volume (30 Days)109.47K
P/E Ratio (Current)-.56
EPS (Current)-$4.50
Dividend Yield0.00%
Free Cash Flow
Cash Ratio1.30
Current Ratio1.41
Quick Ratio1.41
Debt to Equity0.00
Enterprise Value$4.68M
EV to EBITDA-0.19
EV to Sales
Price to Book0.90
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-1.09%
Return on Equity-1.60%

Moleculin Biotech Stock Splits

There have been 3 stock splits for Moleculin Biotech (MBRX). The last reverse stock split occured on December 1, 2025 and reduced the outstanding shares at a ratio of 25:1.

DateTypeRatio
Dec 1, 2025Reverse25:1
Mar 22, 2024Reverse15:1
Feb 1, 2021Reverse6:1

Moleculin Biotech Dividends

There have been no dividends for Moleculin Biotech (MBRX).